NextEra Energy Partners Closes IPO

Skadden represented NextEra Energy, Inc., and its wholly owned subsidiary, NextEra Energy Partners, LP, in the latter’s initial public offering, which began trading on June 27 on the New York Stock Exchange under the symbol NEP and closed on July 1. The IPO raised approximately $467 million.
More >>

Tags:  Skadden, Arps, Slate, Meagher & Flom LLP

Cadwalader Advises Smurfit Kappa on €240 Million Trade Receivables Securitisation Refinancing

Cadwalader, Wickersham & Taft LLP, a leading counselor to global financial institutions and corporations, represented Smurfit Kappa Group in its recent five-year trade receivables securitisation programme of up to €240 million maturing in June 2019. The programme utilises Smurfit Kappa’s receivables in France, the United Kingdom and Germany, and will be used to refinance a similar facility that matures in 2015.

More >>

Tags:  Cadwalader, Wickersham & Taft LLP

Weil Advises Scandi Standard on $361 Million IPO

International law firm Weil, Gotshal & Manges advised Scandi Standard, the largest chicken company in the Scandinavian Region, on its initial public offering (“IPO”) on the NASDAQ OMX Stockholm (the “Offering”). The IPO values Scandi Standard at up to SEK 2.4 billion ($361 million).
More >>

Tags:  Weil, Gotshal & Manges, LLP

Gilbert + Tobin advises Wilmar and First Pacific on landmark Goodman Fielder transaction

Gilbert + Tobin is advising a Consortium, comprising Wilmar International Limited (Wilmar) and First Pacific Company Limited (First Pacific), on the Consortium’s proposed acquisition of Goodman Fielder Limited. The transaction is to be implemented by way of a scheme of arrangement and values Goodman Fielder on an enterprise value basis at A$1.9 billion.

More >>

Tags:  Gilbert, LLP

The Cooper Companies Acquires Sauflon Pharmaceuticals

The Cooper Companies, Inc. (NYSE: COO) has announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals Ltd, a European manufacturer and distributor of soft contact lenses and solutions, in a transaction valued at approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 21% year-over-year. The transaction is subject to regulatory approval and is anticipated to close prior to fiscal year end, October 31, 2014.

More >>

Simpson Thacher Represents the Initial Purchasers in a $750 Million Offering of Senior Notes of SBA Communications Corporation

The Firm represented the initial purchasers in connection with the Rule 144A and Reg S offering of $750 million aggregate principal amount of 4.875% Senior Notes due 2022 by SBA Communications Corporation. J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., RBS Securities Inc. and TD Securities (USA) LLC acted as joint book-running managers for the offering. The offering closed on July 1, 2014.

More >>

Tags:  Simpson Thacher & Bartlett LLP

Volvo Cars signs €660 million revolving credit facility

Volvo Car Group (Volvo Cars) has signed a €660 million revolving credit facility with a group of leading global and regional banks, underlining growing global confidence in the Swedish car company’s financial and operational transformation. The €660 million revolving credit facility extends an existing €360 million revolving credit facility signed early in 2013. It will serve as a back-up facility for general corporate purposes and has a tenor of three years with two extension options of one year each. The new credit facility broadens the group of banks working with Volvo Cars.
More >>

Fredrikson & Byron Represents Eurofins Scientific in Agreement to Acquire ViraCor-IBT Laboratories, Inc.

Fredrikson & Byron acted as legal counsel for Eurofins Scientific (EUFI.PA), a global leader in bioanalytical testing and genomic services, in its acquisition of ViraCor-IBT Laboratories, Inc. (VIBT), a leading specialty diagnostics laboratory partner in immunology, infectious disease and allergy testing, for $255 million, subject to post-closing adjustments. Fredrikson also represented Eurofins in its 2014 acquisitions of Merck Millipore’s pharmaceutical discovery and development solutions business in the US and UK, and Underwriters Laboratories’ consumer and municipal water testing business.

More >>

Tags:  Fredrikson & Byron P.A.